State · North Dakota

Attorney General Brown Seeks Court Approval for $400 Million Multistate Settlement with Sandoz over Alleged Conspiracy to Inflate Prices and Limit Competition Published: 10/1/2026

Attorney General Brenna Bird Seeks Court Approval for $400 Million Settlement with Sandoz for Overcharging for Generic Drugs and Limiting Competition

Attorney General Tong Seeks Court Approval for $400 Million Settlement With Sandoz Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Ellison seeks community input on proposed acquisition of Essentia Health by HealthPartners

Attorney General Aaron M. Frey Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Clark Seeks Court Approval for $358,000 Settlement with Sandoz Over Conspiracy to Inflate Prices and Limit Competition

Colorado slated to receive $2.1M from nationwide settlement with Sandoz over illegal generic drug price hikes and collusion

Attorney General Brown Seeks Court Approval for Multistate Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition Published: 10/9/2026

Coalition Seeks Court Approval for Settlement With Ascend, Citron, and Mayne Pharma Over Conspiracy to Inflate Generic Drug Prices

Attorney General Alan Wilson urges consumers to claim compensation for inflated generic drug pricesRead More

Washington settles generic drug cases with Ascend Laboratories, Citron Pharma, and Mayne Pharma

Acting Alaska Attorney General Cori Mills Seeks Court Approval for Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Press Release OCT 8, 2026 AG Sunday’s Antitrust Section Seeks Court Approval for Settlements with 3 Generic Drug Makers Regarding Price Inflation HARRISBURG, Attorney General Dave Sunday joined a coalition of 45 states and territories seeking court approval of three settlements with Ascend Laboratories, Citron Pharma, and Mayne Pharma… Read more

Washington, multistate coalition seek approval for $400 million settlement in drug price-fixing case

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

Attorney General Hilgers Seeks Court Approval for Settlements with Ascend, Citron, and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Tong Seeks Court Approval for Settlements with Ascend, Citron and Mayne Over Conspiracy to Inflate Prices and Limit Competition

Attorney General Brown Urges Consumers to Claim Compensation for Inflated Generic Drug Prices Published: 9/23/2026

MLN Connects Newsletter for August 6, 2026

Attorney General Knudsen urges Montanans to claim compensation for inflated generic drug prices

Attorney General Mike Hilgers Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

AG Campbell Seeks Court Approval For Settlements With Generic Drug Manufacturers Over Conspiracy To Inflate Prices And Limit Competition

Attorney General Clark Encourages Eligible Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Aaron M. Frey Urges Consumer to Claim Compensation for Inflated Generic Drug Prices

Following Settlements With Generic Drug Manufacturers, AG's Office Urges Consumers To Claim Compensation For Inflated Generic Drug Prices

WA consumers urged to claim compensation for inflated generic drug prices

Attorney General Drew Wrigley Warns About Stem Cell Offers

Generic Drug Settlement Distribution

Attorney General Tong Urges Consumers to Claim Compensation for Inflated Generic Drug Prices

Attorney General Rayfield Secures Patient Relief Over Inflated Drug Prices

OIG Report (OEI): North Dakota Medicaid Fraud Control Unit: 2025 Inspection

Tennessee Joins 20-State Coalition Warning of National Security Risks in Pharmaceutical Supply Chain

Attorney General Bonta Urges Consumers to Claim Compensation for Inflated Generic Drug Prices